We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Novel Device Detects COVID-19 Antibodies in Five Minutes

By LabMedica International staff writers
Posted on 30 Nov 2022

Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. More...

A team of scientists has now developed an electrochemical immunosensor that detects antibodies against the virus.

In search of a novel diagnostic method, a group of scientists at the Federal University of the ABC (UFABC, São Paulo, Brazil) opted for a material frequently used in metallurgy – zinc oxide – and combined it for the first time with fluorine-doped tin oxide (FTO) glass, a conductive material used in electrodes for photovoltaics and other advanced applications. The electrode fabricated by the researchers detected COVID-19 antibodies in serum in about five minutes with 88.7% sensitivity and 100% specificity, outperforming even the enzyme-linked immunosorbent assay (ELISA) test, the current gold-standard clinical diagnostic tool. One of the advantages of the electrode they developed is its flexible architecture, which means that it can easily be customized for other diagnostic and biomedical applications using different biomolecules on the zinc oxide nanorods and other target analytes.

Prior knowledge of chemical properties such as the isoelectric point of the virus’s spike protein (S), enabled the group to develop a platform for S to bind electrostatically to zinc oxide nanorods. Zinc oxide is increasingly used to fabricate biosensors because of its versatility and unique chemical, optical and electrical properties. The immunosensor is easy to make and use, and its production cost is relatively low. The nanorods form a film on the FTO’s conductive surface, creating a favorable molecular microenvironment for immobilization of the S protein and making the construct a simple way to detect these antibodies. The researchers will now adapt the platform to make it portable and connectable to mobile devices for use in diagnosing COVID-19 and other infectious diseases.

“The technology is a versatile biosensing platform. As developed by us, it can be modified and customized for serological detection of other diseases of public health interest," said chemist Wendel Alves, lead author and a professor at the Center for Natural and Human Sciences, UFABC.

Related Links:
UFABC


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.